A Debate on Evidentiary Standards for Accelerated Approvals will Continue at the Oncologic Drugs…On October 28, 2021, the Oncologic Drugs Advisory Committee Meeting will hear an update where the confirmatory trial demonstrated a worse…Oct 13, 2021Oct 13, 2021
There are six generics per branded oral product.Several life-saving medicines are too costly. Millions of patients can benefit from pharmaceutical innovation only through generic…Jul 13, 2021Jul 13, 2021
R and D Intelligence in 5 Sec- 237 Original 505(b)(2) Approvals used Published Literature as…Approval under section 505(b)(2) is one of the three types of accepted new drug applications*:Jun 1, 2021Jun 1, 2021
How Effective are Life-Cycle Management Strategies Across Top Pharmaceutical and Biotech Companies?A client recently asked Vivpro- how effective are we compared to our peers on Life Cycle Management strategies?May 28, 2021May 28, 2021
R&D Intelligence in 5 sec — What is the Value of Speed and Quality for Product Development?May 22, 2021May 22, 2021
